201 related articles for article (PubMed ID: 15258572)
21. Low frequency of mtDNA point mutations in patients with PEO associated with POLG1 mutations.
Kollberg G; Jansson M; Pérez-Bercoff A; Melberg A; Lindberg C; Holme E; Moslemi AR; Oldfors A
Eur J Hum Genet; 2005 Apr; 13(4):463-9. PubMed ID: 15702133
[TBL] [Abstract][Full Text] [Related]
22. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes.
Kasahara T; Kubota M; Miyauchi T; Noda Y; Mouri A; Nabeshima T; Kato T
Mol Psychiatry; 2006 Jun; 11(6):577-93, 523. PubMed ID: 16619054
[TBL] [Abstract][Full Text] [Related]
23. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
Luoma P; Melberg A; Rinne JO; Kaukonen JA; Nupponen NN; Chalmers RM; Oldfors A; Rautakorpi I; Peltonen L; Majamaa K; Somer H; Suomalainen A
Lancet; 2004 Sep 4-10; 364(9437):875-82. PubMed ID: 15351195
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders.
Chan SS; Longley MJ; Copeland WC
Hum Mol Genet; 2006 Dec; 15(23):3473-83. PubMed ID: 17088268
[TBL] [Abstract][Full Text] [Related]
25. Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.
González-Vioque E; Blázquez A; Fernández-Moreira D; Bornstein B; Bautista J; Arpa J; Navarro C; Campos Y; Fernández-Moreno MA; Garesse R; Arenas J; Martín MA
Arch Neurol; 2006 Jan; 63(1):107-11. PubMed ID: 16401742
[TBL] [Abstract][Full Text] [Related]
26. The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease.
Sharer JD
IUBMB Life; 2005 Sep; 57(9):607-14. PubMed ID: 16203679
[TBL] [Abstract][Full Text] [Related]
27. Homology modeling of four Y-family, lesion-bypass DNA polymerases: the case that E. coli Pol IV and human Pol kappa are orthologs, and E. coli Pol V and human Pol eta are orthologs.
Lee CH; Chandani S; Loechler EL
J Mol Graph Model; 2006 Sep; 25(1):87-102. PubMed ID: 16386932
[TBL] [Abstract][Full Text] [Related]
28. Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass.
Lone S; Townson SA; Uljon SN; Johnson RE; Brahma A; Nair DT; Prakash S; Prakash L; Aggarwal AK
Mol Cell; 2007 Feb; 25(4):601-14. PubMed ID: 17317631
[TBL] [Abstract][Full Text] [Related]
29. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia.
Longley MJ; Clark S; Yu Wai Man C; Hudson G; Durham SE; Taylor RW; Nightingale S; Turnbull DM; Copeland WC; Chinnery PF
Am J Hum Genet; 2006 Jun; 78(6):1026-34. PubMed ID: 16685652
[TBL] [Abstract][Full Text] [Related]
30. Subnormal levels of POLγA cause inefficient initiation of light-strand DNA synthesis and lead to mitochondrial DNA deletions and progressive external ophthalmoplegia [corrected].
Roos S; Macao B; Fusté JM; Lindberg C; Jemt E; Holme E; Moslemi AR; Oldfors A; Falkenberg M
Hum Mol Genet; 2013 Jun; 22(12):2411-22. PubMed ID: 23446635
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the catalytic alpha subunit of E. coli replicative DNA polymerase III.
Lamers MH; Georgescu RE; Lee SG; O'Donnell M; Kuriyan J
Cell; 2006 Sep; 126(5):881-92. PubMed ID: 16959568
[TBL] [Abstract][Full Text] [Related]
32. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
[TBL] [Abstract][Full Text] [Related]
33. Chimeric thermostable DNA polymerases with reverse transcriptase and attenuated 3'-5' exonuclease activity.
Schönbrunner NJ; Fiss EH; Budker O; Stoffel S; Sigua CL; Gelfand DH; Myers TW
Biochemistry; 2006 Oct; 45(42):12786-95. PubMed ID: 17042497
[TBL] [Abstract][Full Text] [Related]
34. A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia.
Deschauer M; Hudson G; Müller T; Taylor RW; Chinnery PF; Zierz S
Neuromuscul Disord; 2005 Apr; 15(4):311-5. PubMed ID: 15792871
[TBL] [Abstract][Full Text] [Related]
35. Mutations in human DNA polymerase γ confer unique mechanisms of catalytic deficiency that mirror the disease severity in mitochondrial disorder patients.
Sohl CD; Kasiviswanathan R; Copeland WC; Anderson KS
Hum Mol Genet; 2013 Mar; 22(6):1074-85. PubMed ID: 23208208
[TBL] [Abstract][Full Text] [Related]
36. A novel polymerase gamma mutation in a family with ophthalmoplegia, neuropathy, and Parkinsonism.
Mancuso M; Filosto M; Oh SJ; DiMauro S
Arch Neurol; 2004 Nov; 61(11):1777-9. PubMed ID: 15534189
[TBL] [Abstract][Full Text] [Related]
37. Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs.
Lim SE; Ponamarev MV; Longley MJ; Copeland WC
J Mol Biol; 2003 May; 329(1):45-57. PubMed ID: 12742017
[TBL] [Abstract][Full Text] [Related]
38. Differential phenotypes of active site and human autosomal dominant progressive external ophthalmoplegia mutations in Drosophila mitochondrial DNA helicase expressed in Schneider cells.
Matsushima Y; Kaguni LS
J Biol Chem; 2007 Mar; 282(13):9436-9444. PubMed ID: 17272269
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis.
Hance N; Ekstrand MI; Trifunovic A
Hum Mol Genet; 2005 Jul; 14(13):1775-83. PubMed ID: 15888483
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the catalytic core of human DNA polymerase kappa.
Uljon SN; Johnson RE; Edwards TA; Prakash S; Prakash L; Aggarwal AK
Structure; 2004 Aug; 12(8):1395-404. PubMed ID: 15296733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
